Mark Kupersmith is an Ophthalmology physician affiliated with New York Eye and Ear Infirmary. OpenAlex indexes 331 publications with 15,009 citations (h-index 63); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Ophthalmology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1000 10th Ave
10th Fl Rm Inn
New York, NY 100191147
Telephone
212-636-3200Registry record last updated 15 Jan 2014.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Dompe Farmaceutici S.p.A.Program year202510 payments$25,590openpaymentsdata.cms.gov ↗
- UCB SAProgram year20253 payments
- Janssen Biotech, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
49.8%Prostaglandin Analog31.7%Latanoprost100%Part D≥46 patientsCarbonic Anhydrase Inhibitor12.8%Dorzolamide-Timolol78%Simbrinza22%Part D<11 patients+ 1 more class in this area
Nervous system
21.7%Cholinesterase Inhibitor12.8%Pyridostigmine Bromide100%Part D≥17 patientsSSRI3.5%Fluoxetine Hcl100%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
17.8%Corticosteroid14.8%Prednisone100%Part D≥25 patientsPotassium supplement3%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
8 NIH research awards on record, funded 1985–2022 per NIH RePORTER. The latest:
- Statistical Unsupervised Learning VF for IIHTT & ONTT
Icahn School of Medicine at Mount Sinai
FY2022$164,163R21EY032522 - Statistical Unsupervised Learning VF for IIHTT & ONTT
Icahn School of Medicine at Mount Sinai
FY2021$331,170R21EY032522
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Janet Serle, MD
New York Eye and Ear Infirmary
Ronald Gentile, MD
New York Eye and Ear Infirmary
Paul Sidoti, MD
New York Eye and Ear Infirmary
Kateki Vinod, MD
New York Eye and Ear Infirmary
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”